Overview

A Clinical Trial for Azvudine in the Treatment of Novel Coronavirus Pneumonia (COVID-19）

Status:
Not yet recruiting
Trial end date:
2020-08-12
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of azvudine in treatment of COVID-19
Phase:
N/A
Details
Lead Sponsor:
HeNan Sincere Biotech Co., Ltd